|
GIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66289204628356E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8686163727466E-12 |
| Normal-vs-Stage2 |
6.75239999470278E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
5.329500E-02 |
| Stage1-vs-Stage3 |
1.989740E-02 |
| Stage1-vs-Stage4 |
2.02059999999671E-05 |
| Stage2-vs-Stage3 |
2.622100E-03 |
| Stage2-vs-Stage4 |
1.72869999999214E-05 |
| Stage3-vs-Stage4 |
6.147700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.6621374255883E-15 |
| Normal-vs-AfricanAmerican |
2.84279999984705E-07 |
| Normal-vs-Asian |
7.57272022866573E-12 |
| Caucasian-vs-AfricanAmerican |
5.327200E-01 |
| Caucasian-vs-Asian |
3.360200E-01 |
| AfricanAmerican-vs-Asian |
9.532600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6565637750432E-12 |
| Normal-vs-Female |
1.67355018731996E-12 |
| Male-vs-Female |
6.528800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.33697563709757E-14 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
7.52380000000885E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.999800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.017000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.580000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.139400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.900400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.580000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.8178999999785E-06 |
| Classical-VS-Follicular |
6.977100E-04 |
| Classical-VS-Other |
8.255600E-01 |
| Classical-VS-Normal |
1.74238401484672E-12 |
| Tall-VS-Follicular |
9.93169990692877E-10 |
| Tall-VS-Other |
1.880950E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.305600E-01 |
| Follicular-VS-Normal |
1.28440003077657E-09 |
| Other-VS-Normal |
4.647300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.88178419700125E-16 |
| N0-vs-N1 |
3.979400E-03 |
|
|
